Hims & Hers Health is trading at €26.86, 3.71% up now as investors reassess the impact of the FTC lawsuit.
- The August 7 rally followed the stock’s recovery of its losses and continued a sharp rebound from the July 29 FTC lawsuit-driven decline.
- Healthcare sentiment provided broader support, with the sector gaining 1.3% on August 7.
- The company is scheduled to report second-quarter results on August 10.